Literature DB >> 10415518

Mitochondrial ATP-dependent potassium channels. Viable candidate effectors of ischemic preconditioning.

Y Liu1, T Sato, J Seharaseyon, A Szewczyk, B O'Rourke, E Marbán.   

Abstract

Pharmacological evidence has implicated ATP-dependent potassium (KATP) channels in the mechanism of ischemic preconditioning; however, the effects of sarcolemmal KATP channels on excitability cannot account for the protection. KATP channels also exist in mitochondrial inner membrane. To test whether such channels play a role in cardioprotection, we simultaneously measured flavoprotein fluorescence, an index of mitochondrial redox state, and sarcolemmal KATP currents in intact rabbit ventricular myocytes. Our results show that diazoxide, a KATP channel opener, induced reversible oxidation of flavoproteins, but did not activate sarcolemmal KATP channels. This effect of diazoxide was blocked by 5-hydroxydecanoic acid (5-HD). We further verified that 5-HD is a selective blocker of the mitochondrial KATP channels. These methods have enabled us to demonstrate that the activity of mitochondrial KATP channels can be regulated by protein kinase C. In a cellular model of simulated ischemia, inclusion of diazoxide decreased the rate of cell death to about half of that in control. Such protection is inhibited by 5-HD. In conclusion, our results demonstrate that diazoxide targets mitochondrial but not sarcolemmal KATP channels, and imply that mitochondrial KATP channels may mediate preconditioning.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415518     DOI: 10.1111/j.1749-6632.1999.tb09222.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  32 in total

1.  Mitochondrial ATP dependent potassium channels mediate non-ischemic preconditioning by tachycardia in dogs.

Authors:  P Macho; E Solis; G Sánchez; H Schwarze; R Domenech
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

Review 2.  The surprising role of vascular K(ATP) channels in vasospastic angina.

Authors:  Eduardo Marbán
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

3.  SUR2A C-terminal fragments reduce KATP currents and ischaemic tolerance of rat cardiac myocytes.

Authors:  R D Rainbow; D Lodwick; D Hudman; N W Davies; R I Norman; N B Standen
Journal:  J Physiol       Date:  2004-03-12       Impact factor: 5.182

Review 4.  Ion channels and membrane rafts in apoptosis.

Authors:  I Szabò; C Adams; E Gulbins
Journal:  Pflugers Arch       Date:  2004-04-08       Impact factor: 3.657

Review 5.  Physiology of potassium channels in the inner membrane of mitochondria.

Authors:  Ildikò Szabò; Luigi Leanza; Erich Gulbins; Mario Zoratti
Journal:  Pflugers Arch       Date:  2011-11-18       Impact factor: 3.657

Review 6.  K+ channels in apoptosis.

Authors:  E D Burg; C V Remillard; J X-J Yuan
Journal:  J Membr Biol       Date:  2006-04-17       Impact factor: 1.843

7.  Protective effect of epimedium combined with oligomeric proanthocyanidins on exercise-induced renal ischemia-reperfusion injury of rats.

Authors:  Hua Zhang; Xiao-Qin Sun; Jian-Min Cao; Hai-Tao Zhou; Xian Guo; Yi Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

8.  The mitochondrial K-ATP channel opener, diazoxide, prevents ischemia-reperfusion injury in the rabbit spinal cord.

Authors:  Glen Roseborough; Daqing Gao; Lei Chen; Michael A Trush; Shaoyu Zhou; G Melville Williams; Chiming Wei
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 9.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 10.  Novel neuroprotective strategies in ischemic retinal lesions.

Authors:  Krisztina Szabadfi; Laszlo Mester; Dora Reglodi; Peter Kiss; Norbert Babai; Boglarka Racz; Krisztina Kovacs; Aliz Szabo; Andrea Tamas; Robert Gabriel; Tamas Atlasz
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.